AIF1 and neoplasm: IBA1, a marker for microglia and macrophages, was more prevalent in saline‐treated mice, indicating elevated microglial and macrophage activity, whereas the combination therapy group showed reduced IBA1+ cells, correlating with diminished inflammation and tumor burden.